Abstract
This cohort study investigates whether brain metastases that manifest after stereotactic radiotherapy with concurrent antibody-drug conjugates are associated with an increased risk of symptomatic radiation necrosis.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have